Prevalence of quinolone resistance determinants in non-typhoidal Salmonella isolates from human origin in Extremadura, Spain

Diagnostic Microbiology and Infectious Disease

Volumn 79, Issue 1, 2014, Pages 64-69

  Campos, Maria Jorge ^a,d   Palomo, Gonzalo ^a   Hormeño, Lorena ^a   Herrera León, Silvia ^b   Domínguez, Lucas ^c   Vadillo, Santiago ^a   Píriz, Segundo ^a   Quesada, Alberto ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d POLYTECHNIC INSTITUTE OF LEIRIA   (Portugal)

Author keywords

Antimicrobial resistance; Ciprofloxacin; GyrA; GyrB; Mobilisable plasmid; Nalidixic acid; ParC; ParE; PMQR; QnrS; Quinolone resistance; Salmonella enterica

Indexed keywords

AMINO ACID; ASPARTIC ACID; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE; BACTERIAL DNA; BACTERIAL PROTEIN; QUINOLONE DERIVATIVE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; CLONAL VARIATION; CLUSTER ANALYSIS; DRUG DETERMINATION; MOLECULAR WEIGHT; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMID; PREVALENCE; PRIORITY JOURNAL; QNRS1 GENE; SALMONELLA; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM; SEROTYPE; SPAIN; CHILD; COHORT ANALYSIS; DRUG EFFECTS; GENETICS; HUMAN; MALE; MICROBIOLOGY; MOLECULAR GENETICS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SALMONELLA INFECTIONS;

BACTERIAL PROTEINS; BASE SEQUENCE; CHILD; COHORT STUDIES; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PREVALENCE; QUINOLONES; SALMONELLA ENTERITIDIS; SALMONELLA INFECTIONS; SPAIN;

EID: 84898466239     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.01.010     Document Type: Article

References (46)

1. Aarestrup F.M., Wiuff C., Molbak K., Threlfall E.J. Is it time to change fluoroquinolone breakpoints for Salmonella spp.?. Antimicrob Agents Chemother 2003, 47:827-829.
2. Akiyama T., Khan A. Isolation and characterization of small qnrS1-carrying plasmids from imported seafood isolates of Salmonella enterica that are highly similar to plasmids of clinical isolates. FEMS Immunol Med Microbiol 2012, 64:429-432.
3. Anderson E.S., Ward L.R., Desaxe M.J., de Sa J.D. Bacteriophage-typing designations of Salmonella Typhimurium. J Hyg (Lond) 1977, 78:297-300.
4. Andriole V.T. The quinolones: past, present, and future. Clin Infect Dis 2005, 41:113-119.
5. Antunes P., Mourão J., Machado J., Peixe L. First description of qnrS1-IncN plasmid in a ST11 Salmonella Enteritidis clinical isolate from Portugal. Diagn Microbiol Infect Dis 2011, 69:463-465.
6. Baucheron S., Tyler S., Boyd D., Mulvey M.R., Chaslus-Dancla E., Cloeckaert A. AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium DT104. Antimicrob Agents Chemother 2004, 48:3729-3735.
7. Biedenbach D.J., Toleman M., Walsh T.R., Jones R.N. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn Microbiol Infect Dis 2006, 54:13-21.
8. Campos M.J., Palomo G., Hormeño L., Ugarte M., Porrero M.C., Herrera-León S., et al. Co-occurrence of ACSSuT and cephalosporin resistance phenotypes is mediated by int1-associated elements in nontyphoidal Salmonella enterica from human infections in Spain. Microb Drug Resist 2013, 19:384-391.
9. Carattoli A., Bertini A., Villa L., Falbo V., Hopkins K.L., Threlfall E.J. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005, 63:219-228.
10. Cattoir V., Nordmann P. Plasmid-mediated quinolone resistance in gram-negative bacterial species: an update. Curr Med Chem 2009, 16:1028-1046.
11. Cattoir V., Poirel L., Rotimi V., Soussy C.J., Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 2007, 60:394-397.
12. Cavaco L.M., Hasman H., Xia S., Aarestrup F.M. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica Serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother 2009, 53:603-608.
13. Choi S.H., Woo J.H., Lee J.E., Park S.J., Choo E.J., Kwak Y.G., et al. Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance. J Antimicrob Chemother 2005, 56:1111-1114.
14. DIN. Deutsches Institut für Normung. Part I: Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases (ISO 20776-1:2006). In: Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices. Berlin: Beuth Verlag, 2007.
15. Eaves D.J., Randall L., Gray D.T., Buckley A., Woodward M.J., White A.P., et al. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica. Antimicrob Agents Chemother 2004, 48:4012-4015.
16. Escribano I., Rodriguez J.C., Royo G. Mutations in the gyrA gene in Salmonella enterica clinical isolates with decreased ciprofloxacin susceptibility. Int J Antimicrob Agents 2004, 24:300-303.
17. EFSA (European Food Safety Authority), ECDC (European Centre for Disease Prevention and Control) The European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in the European Union in 2009. EFSA Journal 2011, 9:2154.
18. Fàbrega A., Madurga S., Giralt E., Vila J. Mechanism of action of and resistance to quinolones. Microb Biotechnol 2009, 2:40-61.
19. Fàbrega A., Sanchez-Cespedes J., Soto S., Vila J. Quinolone resistance in the food chain. Int J Antimicrob Agents 2008, 31:307-315.
20. Giraud E., Baucheron S., Cloeckaert A. Resistance to fluoroquinolones in Salmonella: emerging mechanisms and resistance prevention strategies. Microbes Infect 2006, 8:1937-1944.
21. Giraud E., Brisabois A., Martel J.L., Chaslus-Dancla E. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob Agents Chemother 1999, 43:2131-2137.
22. Gunell M., Webber M.A., Kotilainen P., Lilly A.J., Caddick J.M., Jalava J., et al. Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype. Antimicrob Agents Chemother 2009, 53:3832-3836.
23. Hakanen A.J., Lindgren M., Huovinen P., Jalava J., Siitonen A., Kotilainen P. New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility. J Clin Microbiol 2005, 43:5775-5778.
24. Herrera-León S., González-Sanz R., Herrera-León L., Echeita A. Characterization of multidrug-resistant Enterobacteriaceae carrying plasmid-mediated quinolone resistance mechanisms in Spain. J Antimicrob Chemother 2011, 66:287-290.
25. Hopkins K.L., Davies R.H., Threlfall E.J. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 2005, 25:358-373.
26. Hopkins K.L., Wootton L., Day M.R., Threlfall E.J. Plasmid-mediated quinolone resistance determinant qnrS1 found in Salmonella enterica strains isolated in the UK. J Antimicrob Chemother J Antimicrob Chemother 2007, 59:1071-1075.
27. Humphries R.M., Fang F.C., Aarestrup F.M., Hindler J.A. In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards. Clin Infect Dis 2012, 55:1107-1113.
28. Kehrenberg C., Hopkins K.L., Threlfall E.J., Schwarz S. Complete nucleotide sequence of a small qnrS1-carrying plasmid from Salmonella enterica subsp. enterica Typhimurium DT193. J Antimicrob Chemother 2007, 60:903-905.
29. Kim H.B., Park C.H., Kim C.J., Kim E.C., Jacoby G.A., Hooper D.C. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother 2009, 53:639-645.
30. Lavilla S., Gonzalez-Lopez J.J., Sabate M., Garcia-Fernandez A., Larrosa M.N., Bartolome R.M., et al. Prevalence of qnr genes among extended-spectrum beta-lactamase-producing enterobacterial isolates in Barcelona, Spain. J Antimicrob Chemother 2008, 61:291-295.
31. Lindgren M.M., Kotilainen P., Huovinen P., Hurme S., Lukinmaa S., Webber M.A., et al. Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland. Emerg Infect Dis 2009, 15:809-812.
32. Lunn A.D., Fabrega A., Sanchez-Cespedes J., Vila J. Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates. Int Microbiol 2010, 13:15-20.
33. Marimon J.M., Gomariz M., Zigorraga C., Cilla G., Perez-Trallero E. Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003. Antimicrob Agents Chemother 2004, 48:3789-3793.
34. Molbak K., Baggesen D.L., Aarestrup F.M., Ebbesen J.M., Engberg J., Frydendahl K., et al. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104. N Engl J Med 1999, 341:1420-1425.
35. Palomo G., Campos M.J., Ugarte M., Porrero M.C., Alonso J.M., Borge C., et al. Dissemination of antimicrobial-resistant clones of Salmonella enterica among domestic animals, wild animals, and humans. Foodborne Pathog Dis 2013, 10:171-176.
36. Park C.H., Robicsek A., Jacoby G.A., Sahm D., Hooper D.C. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2006, 50:3953-3955.
37. Randall L.P., Coldham N.G., Woodward M.J. Detection of mutations in Salmonella enterica gyrA, gyrB, parC and parE genes by denaturing high performance liquid chromatography (DHPLC) using standard HPLC instrumentation. J Antimicrob Chemother 2005, 56:619-623.
38. Ribot E.M., Fair M.A., Gautom R., Cameron D.N., Hunter S.B., Swaminathan B., et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157: H7 Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 2006, 3:59-67.
39. Schmidt A.J., Ryjenkov D.A., Gomelsky M. The ubiquitous protein domain EAL is a cyclic diguanylate-specific phosphodiesterase: enzymatically active and inactive EAL domains. J Bacteriol 2005, 187:4774-4781.
40. Seminati C., Mejia W., Mateu E., Martin A. Mutations in the quinolone-resistance determining region (QRDR) of Salmonella strains isolated from pigs in Spain. Vet Microbiol 2005, 106:297-301.
41. Soler P., Gonzalez-Sanz R., Bleda M.J., Hernandez G., Echeita A., Usera M.A. Antimicrobial resistance in non-typhoidal Salmonella from human sources, Spain, 2001-2003. J Antimicrob Chemother 2006, 58:310-314.
42. Strahilevitz J., Jacoby G.A., Hooper D.C., Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 2009, 22:664-689.
43. Wang M.H., Guo Q.L., Xu X.G., Wang X.Y., Ye X.Y., Wu S., et al. New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis. Antimicrob Agents Chemother 2009, 53:1892-1897.
44. Ward L.R., Desa J.D.H., Rowe B. A phage-typing scheme for Salmonella enteritidis. Epidemiol Infect 1987, 99:291-294.
45. Weill F.X., Bertrand S., Guesnier F., Baucheron S., Grimont P.A.D., Cloeckaert A. Ciprofloxacin-resistant Salmonella Kentucky in travelers. Emerg Infect Dis 2006, 12:1611-1612.
46. Wu J.J., Ko W.C., Chiou C.S., Chen H.M., Wang L.R., Yan J.J. Emergence of Qnr determinants in human Salmonella isolates in Taiwan. J Antimicrob Chemother 2008, 62:1269-1272.